Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
Author(s) | Date |
Article Title![]() |
Journal |
---|---|---|---|
Jie Zhou, Xun Jiang, Hong Amy Xia, Peng Wei, Brian P. Hobbs |
December 2021 | Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response | Statistics in Medicine |
L. Du, C. Yau, L. Brown-Swigart, R. Gould, G. Krings, G. L. Hirst, I. Bedrosian, R. M. Layman, J.M. Carter, M. Klein, S. Venters, S. Sonal, M. van der Noordaa, A. J. Chien, T. Haddad, C. Isaacs, L. Pusztai, K. Albain, R. Nanda, D. Tripathy, M.C. Liu, J. Boughey, R. Schwab, N. Hylton, A.DeMichele, J. Perlmutter, D. Yee, D. Berry, L. van’t Veer, V. Valero, L. Esserman, W. F.Symmans |
February 2021 | Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to chemo-endocrine therapy | Annals of Oncology |
Fadi S.Dahdaleh, Scott K.Sherman, Hunter D.D.Witmer, Ankit Dhiman, Rahul Rajeev, Elizabeth C.Poli, Fabian M.Johnston, Kiran K.Turagaa |
January 2022 | Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581 | The American Journal of Surgery |
Ran Zeng, Fang Liu, Chen Fang, Jin Yang, Lifeng Luo, Ping Yue, Beili Gao, Yuchao Dong, and Yi Xiang |
October 2021 | PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients | Frontiers in Immunology |
Omar Abdel-Rahman |
June 2018 | Patterns of on-treatment cardiac adverse events within three clinical trials of adjuvant anthracycline-based chemotherapy | Breast Cancer |
Olutomilayo Olayemi Petinrin; Xiangtao Li; Ka-Chun Wong |
August 2021 | Particle Swarm Optimized Gaussian Process Classifier for Treatment Discontinuation Prediction in Multicohort Metastatic Castration-Resistant Prostate Cancer Patients | IEEE Journal of Biomedical and Health Informatics |
Charles Hugh-Jones, Robin Jenkins, Joel Beetsch, Kald Abdallah, Michael Curnyn, Fang Liz Zhou, Mace L. Rothenberg, Gregory A. Curt, John Dornan, Martin J. Murphy |
January 2017 | Overcoming barriers to develop a broad access data sharing platform | Journal of Clinical Oncology |
Charles Hugh-Jones, Robin Jenkins, Joel Beetsch, Kald Abdallah, Michael Curnyn, Fang Liz Zhou, Mace L. Rothenberg, Gregory A. Curt, John Dornan, Martin J. Murphy |
January 2017 | Overcoming barriers to develop a broad access data sharing platform | Journal of Clinical Oncology |
Omar Abdel-Rahman, Hatim Karachiwala, Jacob C. Easaw |
May 2020 | Outcomes of Patients With Advanced Gastrointestinal Cancer in Relationship to Opioid Use: Findings From Eight Clinical Trials | Journal of the National Comprehensive Cancer Network |
Omar Abdel‐Rahman, S. Ghosh, and J. Walker |
February 2020 | Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials | Clinical and Translational Oncology |
Omar Abdel-Rahman |
September 2019 | Outcomes of metastatic breast cancer patients in relationship to disease‐free interval following primary treatment of localized disease; a pooled analysis of two clinical trials | The Breast Journal |
Omar Abdel-Rahman |
June 2018 | Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial | Clinical and Translational Oncology |
Khaled El Emam, Lucy Mosquera, Chaoyi Zheng |
November 2020 | Optimizing the synthesis of clinical trial data using sequential trees | Journal of the American Medical Informatics Association |
Hitesh B. Mistry |
November 2017 | On the relationship between tumour growth rate and survival in non-small cell lung cancer | PeerJ |